The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.
Abstract
Food-borne pathogens are a serious human health concern worldwide, and the emergence of antibiotic-resistant food pathogens has further confounded this problem. Once-highly-efficacious antibiotics are gradually becoming ineffective against many important pathogens, resulting in severe treatment crises. Among several reasons for the development and spread of antimicrobial resistance, their overuse in animal food production systems for purposes other than treatment of infections is prominent. Many pathogens of animals are zoonotic, and therefore any development of resistance in pathogens associated with food animals can spread to humans through the food chain. Human infections by antibiotic-resistant pathogens such as Campylobacter spp., Salmonella spp., Escherichia coli and Staphylococcus aureus are increasing. Considering the human health risk due to emerging antibiotic resistance in food animal–associated bacteria, many countries have banned the use of antibiotic growth promoters and the application in animals of antibiotics critically important in human medicine. Concerted global efforts are necessary to minimize the use of antimicrobials in food animals in order to control the development of antibiotic resistance in these systems and their spread to humans via food and water.
Overview
CoChat Summary
## TL;DR
This paper argues that antimicrobial use in food animals, especially non-therapeutic uses such as growth promotion and prophylaxis, is a major driver of antimicrobial resistance that can spread to humans through the food chain, environment, and farm contact. It supports this with examples and surveillance data showing resistance increases after use of specific drugs and decreases after bans or restrictions.
## Key findings
- The paper states that, globally, 63,200 tons of antibiotics were used in livestock in 2010, and this is estimated to rise by 67% to 105,600 tons by 2030.
- In the United States, an estimate from 2012 found that 72.5% of 12,272 tons of medically important antibiotics were used in animals and 27.5% in humans; it also says nearly 80% of antibiotics produced in the U.S. are used in animal husbandry.
- It reports that food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria than those from farms not using AGPs, and a U.S. study found poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli than community referents.
- Specific examples link use and resistance: avoparcin in chicks led to vancomycin-resistant Enterococcus faecium (VRE), and banning avoparcin in the European Union in 1997 decreased VRE in poultry and the community; reduced tylosin use in 1998–1999 was followed by decreased erythromycin resistance in E. faecium and E. faecalis from pigs.
## Methods
- Not stated in the paper.
- The article is a narrative review that synthesizes prior studies, surveillance reports, and policy examples on antimicrobial use in food production and resistance development.
- Its main analysis is qualitative: it links mechanisms of resistance with historical and current evidence from livestock, poultry, aquaculture, farm workers, and human infections.
## Limitations
- The paper states that “the actual impact of the effect of antimicrobial use and the resultant resistance development by human pathogenic bacteria is a topic of intense debate.”
- It also notes that “a multiplicity of factors contribute to AMR development,” suggesting antimicrobial use is not the only driver.
- Evident from the text: the paper is a broad review rather than an original empirical study, so its conclusions depend on previously published studies and examples rather than a single unified dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 2 Not valid · 28 Not checked · 8 Own results and interpretations
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin.”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 4. Antimicrobial Use and the Development of Resistance in Food Production Environments The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria can be easily transmitted to humans via food from farm animals; (iii) these antibiotic-resistant bacteria can spread to the environment through animal waste leading to wider dissemination; (iv) bacteria can transmit their resistance genotypes to human pathogens not associated with the animals via genetic element transfer mechanisms [79]. Several studies have shown that the regular use of antimicrobials in food animals and birds results in the development of antimicrobial resistance among commensal bacteria. A recent study involving seven European countries found a strong correlation between the levels of antimicrobials used and the resistances of commensal E. coli isolates towards those antibiotics in pigs, poultry and cattle [80]. The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82]. The effect of antimicrobial use is not restricted to the farm environment. Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83]. Environmental bacteria exposed to sub-lethal concentrations of antimicrobials can develop resistance, and through genetic exchange mechanisms, the resistance phenotype gets gradually disseminated among pathogenic and non-pathogenic bacteria. An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84]. The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85]. The connection between antibiotic use and resistance development was first observed in E. coli isolated from the gut of chickens fed with streptomycin [86]. Some of the important pathogens of particular consideration with respect to their development of resistance to the above three classes of drugs include Clostridium difficile, Campylobacter, Salmonella, Shigella, and S. aureus. Currently, several antimicrobials of human medical use are being used in livestock, poultry, and aquaculture (Table 2). Some of these such as the fluoroquinolones are critical for the treatment of Gram-negative infections in humans, and their use in food animals may jeopardize the efficacy of these antibiotics due to the development of resistance in pathogens of zoonotic potential [87]. Scientifically based investigations suggest a strong relationship between antibiotic use in food animals and the development of antibiotic resistance by bacteria associated with farm animals [88,89,90]. There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91]. Food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria compared to those from farms not using AGPs [92]. Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93]. A study in the USA revealed that poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli compared with community referents [94]. It has been experimentally shown that the use of avoparcin in chicks resulted in the development of vancomycin resistance by Enterococcus faecium (VRE), and such bacteria could be transmitted to humans via their consumption of meat contaminated with VRE [74]. Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95]. The decrease in the use of tylosin during 1998 and 1999 was followed by a decrease in erythromycin resistance among E. faecium and E. faecalis isolates from pigs [96]. An increased occurrence of virginiamycin resistance among E. faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96]. A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97]. Quinolonesand third and fourth generation cephalosporins are important in treating salmonellosis in humans, and their widespread use in animal husbandry has selected for resistant strains that can potentially jeopardize their human clinical application [98]. A surveillance study in the USA revealed a strong association between the rise in ciprofloxacin resistance in Campylobacter spp. and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99]. A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100]. The introduction of fluoroquinolones for the treatment of respiratory diseases led to the emergence of fluoroquinolone-resistant Campylobacter [88,101]. The use of third generation cephalosporins led to an increase in the number of cephalosporin-resistant Salmonella strains [102]. A study by Alexander et al. [103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E. coli in cattle. The development of multidrug resistance in E. coli and Salmonella in swine fed with antimicrobial feed has been reported by several investigators [104,105,106,107]. Similarly, it has been reported that macrolides, which are widely used in food animals, result in the selection of macrolide-resistant Campylobacter spp. [98]. Considering the importance of macrolides in the treatment of Campylobacter infections in children, its use in food animals requires critical rethinking. Another serious pathogen associated with livestock and which poses the danger of transmission via food-producing animals is the methicillin-resistant Staphylococcus aureus (MRSA). A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108]. However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin. Historically, when antimicrobial agents were first used in agriculture, such as in food production environments, bacterial multidrug-resistant variants of S. enterica and E. coli soon emerged [109,110]. Shortly after the emergence of this multidrug resistance occurred, transfer of the resistance determinants was detected in the form of plasmids, thus facilitating their movement from food animals to humans and the subsequent transmission to the gastrointestinal tract of new human hosts [91,111]. Together, mobile genetic transfer elements (e.g., bacteriophages, plasmids, gene cassettes, integrons, transposons) and various modes of infection transmission (e.g., direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113]. These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114]. Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122]. Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124]. Policy practices implemented in Europe in which antimicrobial non-therapeutic uses are completely banned (e.g., avoparcin and virginiamycin) in agriculture settings have resulted in reductions in both the prevalence of multidrug-resistant pathogens and in the minimal inhibitory concentrations (MICs) for clinically relevant antimicrobials, such as vancomycin [92,124]. Despite the extensive amount of work over a span of 50 years definitively demonstrating an association between antimicrobial agents and the incidence and prevalence of multiple drug-resistant microorganisms in food production circles [125], the issue remains surprisingly controversial in agriculture, but apparently not in human healthcare settings. Therefore, with respect to antimicrobial usage in agriculture, more work will be necessary to gain a fuller understanding of the nature and extent of the resistance prevalence problem, the overall efficacy of the antimicrobial bans, and the resulting improvement in human health [92]. A review study by the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) on the impact of measures taken to reduce the use of antimicrobials in food-producing animals on the occurrence of antimicrobial resistance (AMR) in bacteria from food-producing animals suggested an association between the reduction in antimicrobial use and reduced AMR [126], although a multiplicity of factors contribute to AMR development. An integrated approach involving different stakeholders to reduce the use of antimicrobials in animals has been recommended, which emphasizes better management practices to reduce the risks of disease, searching for alternative strategies such as competitive exclusion of pathogens, immunostimulants, probiotics, and bacteriophages, and avoiding the preventive use of antimicrobials, etc. [126].
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 4. Antimicrobial Use and the Development of Resistance in Food Production Environments The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria can be easily transmitted to humans via food from farm animals; (iii) these antibiotic-resistant bacteria can spread to the environment through animal waste leading to wider dissemination; (iv) bacteria can transmit their resistance genotypes to human pathogens not associated with the animals via genetic element transfer mechanisms [79]. Several studies have shown that the regular use of antimicrobials in food animals and birds results in the development of antimicrobial resistance among commensal bacteria. A recent study involving seven European countries found a strong correlation between the levels of antimicrobials used and the resistances of commensal E. coli isolates towards those antibiotics in pigs, poultry and cattle [80]. The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82]. The effect of antimicrobial use is not restricted to the farm environment. Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83]. Environmental bacteria exposed to sub-lethal concentrations of antimicrobials can develop resistance, and through genetic exchange mechanisms, the resistance phenotype gets gradually disseminated among pathogenic and non-pathogenic bacteria. An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84]. The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85]. The connection between antibiotic use and resistance development was first observed in E. coli isolated from the gut of chickens fed with streptomycin [86]. Some of the important pathogens of particular consideration with respect to their development of resistance to the above three classes of drugs include Clostridium difficile, Campylobacter, Salmonella, Shigella, and S. aureus. Currently, several antimicrobials of human medical use are being used in livestock, poultry, and aquaculture (Table 2). Some of these such as the fluoroquinolones are critical for the treatment of Gram-negative infections in humans, and their use in food animals may jeopardize the efficacy of these antibiotics due to the development of resistance in pathogens of zoonotic potential [87]. Scientifically based investigations suggest a strong relationship between antibiotic use in food animals and the development of antibiotic resistance by bacteria associated with farm animals [88,89,90]. There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91]. Food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria compared to those from farms not using AGPs [92]. Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93]. A study in the USA revealed that poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli compared with community referents [94]. It has been experimentally shown that the use of avoparcin in chicks resulted in the development of vancomycin resistance by Enterococcus faecium (VRE), and such bacteria could be transmitted to humans via their consumption of meat contaminated with VRE [74]. Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95]. The decrease in the use of tylosin during 1998 and 1999 was followed by a decrease in erythromycin resistance among E. faecium and E. faecalis isolates from pigs [96]. An increased occurrence of virginiamycin resistance among E. faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96]. A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97]. Quinolonesand third and fourth generation cephalosporins are important in treating salmonellosis in humans, and their widespread use in animal husbandry has selected for resistant strains that can potentially jeopardize their human clinical application [98]. A surveillance study in the USA revealed a strong association between the rise in ciprofloxacin resistance in Campylobacter spp. and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99]. A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100]. The introduction of fluoroquinolones for the treatment of respiratory diseases led to the emergence of fluoroquinolone-resistant Campylobacter [88,101]. The use of third generation cephalosporins led to an increase in the number of cephalosporin-resistant Salmonella strains [102]. A study by Alexander et al. [103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E. coli in cattle. The development of multidrug resistance in E. coli and Salmonella in swine fed with antimicrobial feed has been reported by several investigators [104,105,106,107]. Similarly, it has been reported that macrolides, which are widely used in food animals, result in the selection of macrolide-resistant Campylobacter spp. [98]. Considering the importance of macrolides in the treatment of Campylobacter infections in children, its use in food animals requires critical rethinking. Another serious pathogen associated with livestock and which poses the danger of transmission via food-producing animals is the methicillin-resistant Staphylococcus aureus (MRSA). A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108]. However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin. Historically, when antimicrobial agents were first used in agriculture, such as in food production environments, bacterial multidrug-resistant variants of S. enterica and E. coli soon emerged [109,110]. Shortly after the emergence of this multidrug resistance occurred, transfer of the resistance determinants was detected in the form of plasmids, thus facilitating their movement from food animals to humans and the subsequent transmission to the gastrointestinal tract of new human hosts [91,111]. Together, mobile genetic transfer elements (e.g., bacteriophages, plasmids, gene cassettes, integrons, transposons) and various modes of infection transmission (e.g., direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113]. These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114]. Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122]. Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124]. Policy practices implemented in Europe in which antimicrobial non-therapeutic uses are completely banned (e.g., avoparcin and virginiamycin) in agriculture settings have resulted in reductions in both the prevalence of multidrug-resistant pathogens and in the minimal inhibitory concentrations (MICs) for clinically relevant antimicrobials, such as vancomycin [92,124]. Despite the extensive amount of work over a span of 50 years definitively demonstrating an association between antimicrobial agents and the incidence and prevalence of multiple drug-resistant microorganisms in food production circles [125], the issue remains surprisingly controversial in agriculture, but apparently not in human healthcare settings. Therefore, with respect to antimicrobial usage in agriculture, more work will be necessary to gain a fuller understanding of the nature and extent of the resistance prevalence problem, the overall efficacy of the antimicrobial bans, and the resulting improvement in human health [92]. A review study by the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) on the impact of measures taken to reduce the use of antimicrobials in food-producing animals on the occurrence of antimicrobial resistance (AMR) in bacteria from food-producing animals suggested an association between the reduction in antimicrobial use and reduced AMR [126], although a multiplicity of factors contribute to AMR development. An integrated approach involving different stakeholders to reduce the use of antimicrobials in animals has been recommended, which emphasizes better management practices to reduce the risks of disease, searching for alternative strategies such as competitive exclusion of pathogens, immunostimulants, probiotics, and bacteriophages, and avoiding the preventive use of antimicrobials, etc. [126].
What the sources say
- Not checked yetcites [52] Andersen, 2015, Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens, Int. J. Environ. Res. Public Health source
- Not checked yetcites [114] Witte, 2000, Selective pressure by antibiotic use in livestock, Int. J. Antimicrob. Agents source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The use of antibiotics for short-term gains has inflicted a long-lasting negative impact on human health and in the environment [14].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
What the sources say
- Not checked yetcites [14] Chattopadhyay, 2014, Use of antibiotics as feed additives: A burning question, Front. Microbiol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the United States, nearly 80% of the antibiotics produced are used in animal husbandry [11].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
What the sources say
- Not checked yetcites [11] United States Food and Drug Administration (2014). Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, United States Food and Drug Administration.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Indiscriminate use of antibiotics for purposes other than treatment of infections has resulted in the emergence of antibiotic-resistant pathogens in food production environments, and such pathogens can cause infections in humans that are difficult to treat or control.”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 38 claims and to verify the 37 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics that have been used in the management of cholera cases for decades such as tetracyclines, which include doxycycline and tetracycline, have been associated with the presence of IncC conjugative plasmids.15,16,17”
From Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya (2020) · cites this paper as [16]
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784 · cited 1×
“However, bacterial pathogens soon exhibited the signs of surviving the lethal effects of antimicrobials, and the first penicillin-resistant Staphylococcus was reported soon after the introduction of penicillin in 1946, although penicillinases were discovered considerably before the discovery of penicillin itself, sugg…”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973 · cited 2×
“Global antimicrobial use in food animals (a) Major users of antimicrobials in livestock in 2010; (b) Major users of antimicrobials in livestock in 2030 (projected) [65].”
BackgroundFood Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241 · cited 7×
“Considering the potential link between the use of antibiotics and their effect on human health, the World Health Organization (WHO) recommended the termination of AGPs belonging to classes of antibiotics used in human treatment and cautious application of other AGPs with routine monitoring of resistance development [1…”
BackgroundInfluentialMobile genetic elements: the agents of open source evolution
Frost, L. S., Leplae, R., Summers, A. O., & Toussaint, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1235 · Cited by 1,847 · cited 1×
“, direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113].”
BackgroundOuter membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762 · cited 1×
“This mechanism is referred to as drug permeability reduction and prevents access of antimicrobial agents to their intracellular drug targets, thus conferring antimicrobial resistance [35,36].”
BackgroundMechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628 · cited 1×
“Infectious diseases were thought to have been controlled, and the magic of antibiotics continued for a specific period of time during the mid-20th century, called the “golden era of antibiotic chemotherapy” [2].”
BackgroundThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614 · cited 2×
“Bacteria harboring these determinants are essentially resistant to clinically important antimicrobials such as the aminoglycosides, the β-lactams, the fluoroquinolones and the chloramphenicols [37].”
BackgroundSampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594 · cited 1×
“However, bacterial pathogens soon exhibited the signs of surviving the lethal effects of antimicrobials, and the first penicillin-resistant Staphylococcus was reported soon after the introduction of penicillin in 1946, although penicillinases were discovered considerably before the discovery of penicillin itself, sugg…”
Background
Research works printed but not linked: 6
- Kumar, S., Floyd, J.T., He, G., and Varela, M.F. (2013). Bacterial Antimicrobial Efflux Pumps of the MFS and Mate Transporter Families: A Review, Research Signpost Inc.
- Prescott, J., and Baggot, J. (1993). Antimicrobial Therapy in Veterinary Medicine, Iowa State University Press. [2nd ed.].
- (2015). Antimicrobials in Agriculture and the Environment: Reducing Unnecessary Use and Wastage. The Review on Antimicrobial Resistance, Antimicrobial Resistance Review (AMR).
- NIAA (2011, January 26–27). Antibiotic Use in Food Animals: A Dialogue for a Common Purpose. Proceedings of the Symposium by National Institute for Animal Agriculture and Conducted, Chicago, IL, USA.
- Vaughn, M., and Copeland, D. (2004, January 6–9). Is there human health harm following fluoroquinolone use in poultry?. Proceedings of the Fifty-Third Western Poultry Disease Conference, Sacramento, CA, USA.
- FAO (2007, January 26–30). Joint FAO/WHO/OIE expert meeting on critically important antimicrobials. Proceedings of the FAO/WHO/OIE Expert Meeting FAO Headquarters, Rome, Italy.
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses
Van, T. T. H., Yidana, Z., Smooker, P. M., & Coloe, P. J. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.07.031 · Cited by 451
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
“Effective clinician–patient communication is essential to provide clear explanations, use specific diagnoses, and offer alternative treatments to reduce unnecessary antibiotic prescription while maintaining patient satisfaction [349].”
Antimicrobial uses for livestock production in developing countries
Hosain, M. Z., Kabir, S. M. L., & Kamal, M. M. (2021) · Veterinary World · doi:10.14202/vetworld.2021.210-221 · Cited by 201
“Penicillin and tetracyclines are the most commonly prescribed antibiotics used for food animals [47], whereas for human therapeutic purpose antimicrobial drug categories as the macrolides, polymyxins, aminoglycosides, and third-generation cephalosporins (Table-2), which are also being used in food animals [8,19,48,49].”
BackgroundSelection and dissemination of antimicrobial resistance in Agri-food production
Cheng, G., Ning, J., Ahmed, S., Huang, J., Ullah, R., An, B., Hao, H., Dai, M., Huang, L., Wang, X., et al. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0623-2 · Cited by 195
“In United States, nearly 80% of antibiotics produced are used in animal husbandry [2].”
Unveiling the Impact of Antibiotics and Alternative Methods for Animal Husbandry: A Review
Low, C. X., Tan, L. T., Mutalib, N. A., Pusparajah, P., Goh, B. H., Chan, K., Letchumanan, V., & Lee, L. (2021) · Antibiotics · doi:10.3390/antibiotics10050578 · Cited by 175
Guo, H., Tong, Y., Cheng, J., Abbas, Z., Li, Z., Wang, J., Zhou, Y., Si, D., & Zhang, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031241 · Cited by 120
“In the past decades, antibiotics have played a significant role in reducing the risks involved in childbirth, injuries, and intrusive medical procedures [1,2].”
BackgroundFormic Acid as an Antimicrobial for Poultry Production: A Review
Ricke, S. C., Dittoe, D. K., & Richardson, K. E. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00563 · Cited by 140
Kumar, S., Lekshmi, M., Parvathi, A., Ojha, M., Wenzel, N., & Varela, M. F. (2020) · Microorganisms · doi:10.3390/microorganisms8020266 · Cited by 112
Self-citationEnvironmental Antimicrobial Resistance: Implications for Food Safety and Public Health
Ifedinezi, O. V., Nnaji, N. D., Anumudu, C. K., Ekwueme, C. T., Uhegwu, C. C., Ihenetu, F. C., Obioha, P., Simon, B. O., Ezechukwu, P. S., & Onyeaka, H. N. (2024) · Antibiotics · doi:10.3390/antibiotics13111087 · Cited by 118
Screening of veterinary drug residues in food by LC-MS/MS. Background and challenges
Delatour, T., Racault, L., Bessaire, T., & Desmarchelier, A. (2018) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2018.1426890 · Cited by 97
“Briefly, antimicrobial resistance happens when microorganisms exposed to antimicrobial drugs change and ultimately impair treatment with antibiotics in human medicine (Hao et al. 2014; Lekshmi et al. 2017).”
BackgroundMitchell, J., Cooke, P., Ahorlu, C., Arjyal, A., Baral, S., Carter, L., Dasgupta, R., Fieroze, F., Fonseca-Braga, M., Huque, R., et al. (2022) · Global Public Health · doi:10.1080/17441692.2021.2003839 · Cited by 94
“…animals is often framed as a negative behaviour under the rationale that it can lead to common infections developing resistance, causing mass sickness in the animals and thus reducing food supplies and economic gains for the farmer (Durso & Cook, 2014;; Founou et al., 2016 Lekshmi et al., 2017).”
BackgroundWhelan, R., Doranalli, K., Rinttilä, T., Vienola, K., Jurgens, G., & Apajalahti, J. (2018) · Poultry Science · doi:10.3382/ps/pey500 · Cited by 103
“and is being phased out of production due to consumer demand in others over the risk of increasing antibiotic resistance in pathogens of veterinary and human medical relevance (Lekshmi et al., 2017).”
BackgroundElkenany, R., El‒Sayed, S. A. E., Zakaria, A. I., El‒Sayed, S. A. E., & Rizk, M. A. (2019) · BMC Veterinary Research · doi:10.1186/s12917-019-1867-z · Cited by 96
Al Banna, M. H., Disu, T. R., Kundu, S., Ahinkorah, B. O., Brazendale, K., Seidu, A.-A., Okyere, J., Rahman, N., Mondal, S., Matubber, B., et al. (2021) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-021-01004-5 · Cited by 79
Probiotics and Postbiotics as an Alternative to Antibiotics: An Emphasis on Pigs
Ali, M. S., Lee, E., Hsu, W. H., Suk, K., Sayem, S. A. J., Ullah, H. M. A., Lee, S., & Park, S. (2023) · Pathogens · doi:10.3390/pathogens12070874 · Cited by 96
Evangelista, A. G., Corrêa, J. A. F., Pinto, A. C. S. M., & Luciano, F. B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1883548 · Cited by 91
“…and animal health and/or production have direct influence on pathogen resistance, while products with exclusive application as AGP can promote resistance to other antibiotics due to chemical and/or functional similarities – a mechanism known as cross-resistance (Lekshmi et al. 2017; Shaw 2019).”
BackgroundLiang, W., Li, H., Zhou, H., Wang, M., Zhao, X., Sun, X., Li, C., & Zhang, X. (2021) · Poultry Science · doi:10.1016/j.psj.2021.01.030 · Cited by 84
“However, the abuse or longterm application of antibiotics leads to the low level of immune system, the production of drug-resistant strains, secondary infection and drug residues, which cause a series of food safety and health problems to human beings and the environment (Dibner and Richards, 2005; M’Sadeq et al., 201…”
BackgroundMa, T., Suzuki, Y., & Guan, L. L. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.10.004 · Cited by 90
Gadde, U. D., Oh, S., Lillehoj, H. S., & Lillehoj, E. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-22004-6 · Cited by 80
RetractedHashanuzzaman, M., Bhowmik, S., Rahman, M. S., Zakaria, M. U. M. A., Voumik, L. C., & Mamun, A.-A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05485 · Cited by 74
Sortase A (SrtA) inhibitors as an alternative treatment for superbug infections
Alharthi, S., Alavi, S. E., Moyle, P. M., & Ziora, Z. M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.019 · Cited by 70
Pan, H., Paudyal, N., Li, X., Fang, W., & Yue, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00023 · Cited by 68
“Therefore, the exact contribution and attribution of antibiotic resistance in pathogenic bacteria of significance to human is an open issue with divided and sometimes contrasting opinions (Phillips et al., 2004; Founou et al., 2016; Lekshmi et al., 2017).”
BackgroundJin, X., Liu, S., Zhang, Z., Liu, T., Li, N., Liang, Y., Zheng, J., & Peng, N. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130261 · Cited by 67
Qamar, M. U., Aatika, A., Chughtai, M. I., Ejaz, H., Mazhari, B. B. Z., Maqbool, U., Alanazi, A., Alruwaili, Y. S., & Junaid, K. (2023) · Microorganisms · doi:10.3390/microorganisms11010161 · Cited by 64
“Antimicrobial resistance (AMR) in the food chain has emerged as a global “One Health” concern [11,12].”
BackgroundMohanty, H., Pachpute, S., & Yadav, R. P. (2021) · Folia Microbiologica · doi:10.1007/s12223-021-00910-z · Cited by 71
Stephen, J., Salam, F., Lekshmi, M., Kumar, S. H., & Varela, M. F. (2023) · Antibiotics · doi:10.3390/antibiotics12020343 · Cited by 68
Self-citationPenagos-Tabares, F., Sulyok, M., Faas, J., Krska, R., Khiaosa‐ard, R., & Zebeli, Q. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120626 · Cited by 57
Tran, T. V., Nguyen, D. T. C., Le, H. T. N., Vo, D. N., Doan, V., Dinh, V., Nguyen, H.-T. T., Nguyen, T. D., & Bạch, L. G. (2019) · Comptes Rendus Chimie · doi:10.1016/j.crci.2019.09.003 · Cited by 55
Liu, M., Feng, P., Kakade, A., Yang, L., Chen, G., Yan, X., Ni, H., Liu, P., Kulshrestha, S., Abomohra, A., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122032 · Cited by 55
Osman, K. M., Badr, J., Orabi, A., Elbehiry, A., Saad, A. S. A., Ibrahim, M. D. S., & Hanafy, M. H. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.01.006 · Cited by 64
Jampasa, S., Pummoree, J., Siangproh, W., Khongchareonporn, N., Ngamrojanavanich, N., Chailapakul, O., & Chaiyo, S. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128389 · Cited by 54
Elez, R. M. M. A., Elsohaby, I., El-Gazzar, N. S., Tolba, H. M. N., Abdelfatah, E. N., Abdellatif, S. S., Mesalam, A. A., & Tahoun, A. B. M. B. (2021) · Animals · doi:10.3390/ani11123554 · Cited by 53
“However, these isolates were overlapped, reflecting the high public health impact of MDR isolates and the need for new antimicrobial agents to treat human salmonellosis [64].”
BackgroundStrategies to Improve Poultry Food Safety, a Landscape Review
Ricke, S. C. (2020) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-061220-023200 · Cited by 50
Rao, M., Padyana, S., Dipin, K. M., Kumar, S. H., Nayak, B. B., & Varela, M. F. (2018) · Journal of Antimicrobial Agents · doi:10.4172/2472-1212.1000159 · Cited by 46
“Further, in silico studies showed that a p-coumaric acid derivative 4(4-((Z)-2-carboxy-2-((Z)-2,3-dihydrobenzo[e][1,4]diazepin-1-yl)-1(4-hydroxyphenyl)vinylamino) phenylsulfonamido)-2-hydroxybenzoic acid was able to dock more efficiently than the parent compound and could act as a more potent inhibitor of RNA efflux p…”
BackgroundSelf-citationZohra, T., Numan, M., Ikram, A., Salman, M., Khan, T., Din, M., Salman, M., Farooq, A., Amir, A., & Ali, M. (2021) · Microorganisms · doi:10.3390/microorganisms9050954 · Cited by 54
“In the mid-20th century, when the clinical practice of antimicrobial drugs was introduced, it revolutionized the public health sector [1].”
BackgroundAlem, K., Dagnew, M., Gizachew, M., Gelaw, B., & Moges, F. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70067 · Cited by 46
“To mitigate this problem, healthcare providers need to engage in thorough discussions with patients, offering clear explanations, accurate diagnoses, and considering alternative treatment options when appropriate (Lekshmi et al. 2017).”
Millanao, A. R., Barrientos-Schaffeld, C., Siegel-Tike, C. D., Tomova, A., Ivanova, L. B., Godfrey, H. P., Dölz, H., Buschmann, A. H., & Cabello, F. C. (2018) · Revista chilena de infectología · doi:10.4067/s0716-10182018000300299 · Cited by 45
Singh, A. S., Nayak, B. B., & Kumar, S. H. (2020) · Veterinary Sciences · doi:10.3390/vetsci7020046 · Cited by 55
“coli is a serious concern, since such bacteria can be introduced via seafood to distant geographical regions, where such resistance patterns were unknown before [5].”
BackgroundSelf-citationRajput, D. S., Zeng, D., Khalique, A., Rajput, S. S., Wang, H., Zhao, Y., Sun, N., & Ni, X. (2020) · AMB Express · doi:10.1186/s13568-020-01153-w · Cited by 53
Lu, W., Wang, M., Wu, J., Jiang, Q., Jin, J., Jin, Q., Yang, W., Chen, J., Wang, Y., & Xiao, M. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.113998 · Cited by 47
Antibiotic prescription for endodontic infections: a survey of Brazilian Endodontists
Bolfoni, M. R., Pappen, F. G., Pereira‐Cenci, T., & Jacinto, R. D. C. (2017) · International Endodontic Journal · doi:10.1111/iej.12823 · Cited by 43
Park, I., Zimmerman, N. P., Smith, A. H., Rehberger, T. G., Lillehoj, E. P., & Lillehoj, H. S. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00123 · Cited by 47
Lika, E., Kostić, M., Vještica, S., Milojević, I., & Puvača, N. (2021) · Sustainability · doi:10.3390/su13158467 · Cited by 42
RetractedPlant-Derived Phytobiotics as Emerging Alternatives to Antibiotics Against Foodborne Pathogens
Rachwał, K., & Gustaw, K. (2025) · Applied Sciences · doi:10.3390/app15126774 · Cited by 52
Valderrama, M. J., González‐Zorn, B., de Pablo, P. C., Diez‐Orejas, R., Fernández‐Acero, T., Gil-Serna, J., de Juan, L., Martı́n, H., Molina, M., Navarro, F., et al. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny161 · Cited by 38
de Oliveira, M. J. K., Sakomura, N. K., Dorigam, J. C. D. P., Doranalli, K., Soares, L., & Viana, G. D. S. (2019) · Poultry Science · doi:10.3382/ps/pez223 · Cited by 38
Zhang, Z., Li, C., Wang, G., Yang, X., Zhang, Y., Wang, R., Angelidaki, İ., & Miao, H. (2023) · Journal of Environmental Management · doi:10.1016/j.jenvman.2023.118459 · Cited by 39
Raafat, D., Mrochen, D. M., Al’Sholui, F., Heuser, E., Ryll, R., Pritchett‐Corning, K. R., Jacob, J., Walther, B., Matuschka, F., Richter, D., et al. (2020) · Toxins · doi:10.3390/toxins12020080 · Cited by 39
“This suggests that SCCmec elements are predominantly acquired and maintained in environments with significant selective pressure due to the use of antibiotics [57,58].”
BackgroundCommunicating Benefits from Vaccines Beyond Preventing Infectious Diseases
Chevalier-Cottin, E.-P., Ashbaugh, H. R., Brooke, N. J., Gavazzi, G., Santillana, M., Burlet, N., & Htar, M. T. T. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00312-7 · Cited by 38
Coppola, N., Freire, B., Umpiérrez, A., Cordeiro, N. F., Ávila, P., Trenchi, G., Castro, G., Casaux, M. L., Fraga, M., Zunino, P., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.588919 · Cited by 35
“C5 20 1 19 0 29 bla((1)) CTX−M−15 qnrB19 ((8)), qnrE1((2)), qnrS1((1)) – blaCTX−M−15/qnrB19((1)), qnrB19((7)), qnrE1((2)), qnrS1((1))”
BackgroundInfluentialThe Influencing Factors of Bacterial Resistance Related to Livestock Farm: Sources and Mechanisms
Guo, K., Zhao, Y., Cui, L., Cao, Z., Zhang, F., Wang, X., Feng, J., & Dai, M. (2021) · Frontiers in Animal Science · doi:10.3389/fanim.2021.650347 · Cited by 38
“After antibiotics are fed to farm animals in low or sub-dose concentrations, 75–90% will be lost to the environment in the form of urine and feces (Lekshmi et al., 2017).”
BackgroundRole of nanotechnology in animal production and veterinary medicine
Ali, A., Ijaz, M. U., Khan, Y. R., Sajid, H. A., Hussain, K., Rabbani, A. H., Shahid, M. F., Naseer, O., Ghaffar, A., Naeem, M. A., et al. (2021) · Tropical Animal Health and Production · doi:10.1007/s11250-021-02951-5 · Cited by 41
Multidrug resistance: a threat to antibiotic era
Fatima, Z., Purkait, D., Rehman, S., Rai, S., & Hameed, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820509-9.00014-9 · Cited by 52
Varela, M. F., Stephen, J., Bharti, D., Lekshmi, M., & Kumar, S. H. (2023) · Biomedicines · doi:10.3390/biomedicines11051448 · Cited by 35
Self-citationPessotti, R. D. C., Hansen, B. L., Reaso, J. N., Ceja-Navarro, J. A., El-Hifnawi, L., Brodie, E., & Traxler, M. F. (2021) · eLife · doi:10.7554/elife.65091 · Cited by 35
Okon, E. M., Okocha, R. C., Adesina, B., Ehigie, J. O., Alabi, O. O., Bolanle, A. M., Matekwe, N., Falana, B. M., Tiamiyu, A. M., Olatoye, I. O., et al. (2022) · Frontiers in Antibiotics · doi:10.3389/frabi.2022.1043302 · Cited by 31
Oladokun, S., & Adewole, D. I. (2023) · Poultry Science · doi:10.1016/j.psj.2022.102473 · Cited by 32
“the risk of the development of antimicrobial resistance, which has undesirable consequences for human and animal health (Van Den Bogaard and Stobberingh, 2000; Diarra and Malouin, 2014; Lekshmi et al., 2017).”
BackgroundAraby, E., Nada, H. G., El-Nour, S. A. A., & Hammad, A. A. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01868-7 · Cited by 30
Li, X., Wang, L., Zhao, L., Li, Y., He, W., Ding, K., & Cao, P. (2024) · Microorganisms · doi:10.3390/microorganisms12040749 · Cited by 37
“This issue poses risks to both animal and human health [1].”
BackgroundMaina, J., Ndung’u, P., Muigai, A. W. T., & Kiiru, J. (2021) · Access Microbiology · doi:10.1099/acmi.0.000236 · Cited by 28
“The heavy usage of human medicine in animal feed production, veterinary, and agriculture have also been determined to be sources of emergence and spread of antimicrobial- resistant bacterial strains [9, 10].”
BackgroundYang, K., Wang, A., Fu, M., Wang, A., Chen, K. M., Jia, Q., & Huang, Z. J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020472 · Cited by 26
Characterization of blaNDM-harboring, multidrug-resistant Enterobacteriaceae isolated from seafood
Das, U. N., Singh, A. S., Lekshmi, M., Nayak, B. B., & Kumar, S. H. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-3759-3 · Cited by 25
“Resistance to antibiotics in bacteria associated with foods of animal origin has become a global concern (Lekshmi et al. 2017).”
BackgroundSelf-citationAwuor, S. O., Omwenga, E. O., & Daud, I. I. (2020) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v12i1.2264 · Cited by 23
Betancur, C., Martínez, Y., Merino-Guzmán, R., Hernández-Velasco, X., Castillo, R., Rodríguez, R., & Téllez‐Isaías, G. (2020) · Animals · doi:10.3390/ani10071218 · Cited by 26
Green Tea (Camellia sinensis) Products as Alternatives to Antibiotics in Poultry Nutrition: A Review
Mahlake, S. K., Mnisi, C. M., Kumanda, C., Mthiyane, D. M. N., & Montso, P. K. (2022) · Antibiotics · doi:10.3390/antibiotics11050565 · Cited by 28
“The antimicrobials routinely used as coccidiostats, such as ionophores and sulphonamides, are also used as prophylactics to prevent coccidiosis [11,26].”
BackgroundWen, C., Zhang, H., Guo, Q., Duan, Y., Chen, S., Han, M., Li, F., Jin, M., & Wang, Y. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200674 · Cited by 26
da Silva, J. B., de Bessa, M. E., Mayorga, O. A. S., Andrade, V. T., da Costa, Y. F. G., Mendes, R. D. F., Ferreira, A. L. P., Scio, E., & Alves, M. S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.07.031 · Cited by 22
The Anti-Campylobacter Activity and Mechanisms of Pinocembrin Action
Klančnik, A., Šimunović, K., Kovač, J., Şahin, O., Wu, Z., Vučković, D., Abram, M., Zhang, Q., & Možina, S. S. (2019) · Microorganisms · doi:10.3390/microorganisms7120675 · Cited by 23
“jejuni and reported that strains with specific polymorphisms are more likely to show increased resistance to tetracycline, doxycycline, florfenicol, chloramphenicol and gentamicin [12,13].”
BackgroundAdhesion of Campylobacter jejuni Is Increased in Association with Foodborne Bacteria
Klančnik, A., Gobin, I., Jeršek, B., Možina, S. S., Vučković, D., Žnidarič, M. T., & Abram, M. (2020) · Microorganisms · doi:10.3390/microorganisms8020201 · Cited by 22
Gupta, M., Raut, R., Manandhar, S., Chaudhary, A., Shrestha, U., Dangol, S., Sudarshan, G. C., Budha, K. R., Karki, G., Sanchez, S. D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280412 · Cited by 21
Strategies for discovery of new molecular targets for anti-infective drugs
Varela, M. F., & Kumar, S. H. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.015 · Cited by 21
Self-citationAljahani, A. H., Alarjani, K. M., Hassan, Z. K., El‐Khadragy, M. F., Ismail, E. A., AL-MASOUD, A. H., & Yehia, H. M. (2020) · Bioscience Reports · doi:10.1042/bsr20193470 · Cited by 22
Desmarchelier, A., Bessaire, T., Savoy, M., Tarres, A., Mujahid, C., Beck, A., Mottier, P., & Delatour, T. (2020) · Journal of AOAC International · doi:10.1093/jaoacint/qsaa168 · Cited by 20
Consumers’ willingness to pay for safer fish: Evidence from experimental auctions in Bangladesh
Dey, M. M., Rahman, M. S., Dewan, M. F., Sudhakaran, P. O., Deb, U., & Khan, M. A. (2024) · Aquaculture Economics & Management · doi:10.1080/13657305.2024.2353212 · Cited by 18
“Animal-source foods, such as meats, fish, and their products, are highly susceptible to foodborne diseases because they are an ideal growth medium for pathogens and other possible contaminants (Lekshmi et al., 2017).”
Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Satish, S., Ranjini, H. K., Manju, K. G., Ravikumara, Chouhan, R. S., Khohlova, O. Y., et al. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100122 · Cited by 20
Amin, M. A., Hashem, H. R., El-Mahallawy, H. S., Abdelrahman, A. A., Zaki, H. M., & Azab, M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105538 · Cited by 16
Resende, J. A., Fontes, C. O., Machado, A. B. F., Nascimento, T. C., da Silva, V. L., & Diniz, C. G. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14019 · Cited by 17
Jabbar, M., Baboo, I., Majeed, H., Farooq, Z., Palangı, V., & Lackner, M. K. (2024) · Animals · doi:10.3390/ani14192860 · Cited by 15
“Unfortunately, the extensive use of synthetic AGPs has led to antibiotic resistance, posing environmental and public health risks [3,4].”
BackgroundGuo, L., Wu, X., Liu, L., Kuang, H., & Xu, C. (2019) · Biotechnology Journal · doi:10.1002/biot.201900174 · Cited by 15
Su, Y.-L., Wang, G., Wang, J., Xie, B., Gu, Q.-Q., Hao, D., Liu, H., & Zhang, M. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.01.057 · Cited by 15
Almada‐Leyva, M. L., Tecuapa-Flores, E. D., Rojas, L. M. G., & Thangarasu, P. (2024) · Electroanalysis · doi:10.1002/elan.202300398 · Cited by 14
Chen, J., Yan, F., Kuttappan, V. A., Cook, K., Buresh, B., Roux, M., Hancock, D. L., & Vazquez-Anon, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.991320 · Cited by 14
“The use of antibiotics as growth promoters in animal feed has been recognized to contribute to the emergence of antibioticresistant bacteria, which could be transferred to humans reducing the sensitivity of human disease treatment with certain drugs (Lekshmi et al., 2017; Tang et al., 2017).”
BackgroundMedicinal Plants and Natural Substances for Poultry Health: A Review
Pashaei, M., Zeroual, F., Kahrizi, D., & Erċışlı, S. (2024) · Journal of Poultry Sciences and Avian Diseases · doi:10.61838/kman.jpsad.2.2.5 · Cited by 16
de Sales, C. V., de Melo, A. N. F., Niedzwiedzka, K. M., de Souza, E. L., Schaffner, D. W., & Magnani, M. (2018) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-18-213 · Cited by 13
Dey, T. K., Shome, B. R., Bandyopadhyay, S., Goyal, N. K., Lundkvist, Å., Deka, R. P., Shome, R., Venugopal, N., Grace, D., Sharma, G., et al. (2023) · Pathogens · doi:10.3390/pathogens12020344 · Cited by 12
“Infections caused by resistant bacterial strains in humans are on the rise, including infections caused by Staphylococcus spp., Escherichia coli [4], Salmonella spp. [ 16], and Campylobacter spp. [ 17].”
da Silva, P. B., Araújo, V. H. S., Fonseca‐Santos, B., Solcia, M. C., Ribeiro, C. M., da Silva, I. C., Alves, R. C., Pironi, A. M., Silva, A. C. L., Victorelli, F. D., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200513080719 · Cited by 12
Salis, S., Rubattu, N., Rubattu, F., Cossu, M., Sanna, A., & Chessa, G. (2022) · Molecules · doi:10.3390/molecules27196162 · Cited by 11
“The contamination of food with residues of veterinary drugs, indeed, can give rise to allergic reactions in hypersensitive subjects, alterations of the intestinal bacterial flora, and can contribute to antimicrobial resistance phenomena in some bacterial strains, which is considered an increasing threat to public heal…”
BackgroundRafei, R., Kassaa, I. A., Osman, M., Dabboussi, F., & Hamzé, M. (2019) · British Poultry Science · doi:10.1080/00071668.2019.1645945 · Cited by 11
“This alarming upswing has been partly attributed to the overuse of antibiotics in the animal production industry (Lekshmi et al. 2017).”
BackgroundSachithanandan, J. S., Deepalakshmi, M., Rajamohamed, H., Mary, P., Mohankumar, M., & Vikashini, S. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.2.30 · Cited by 10
“11,12 ADC’s extremely potent payloads and uptake through endocytosis and drug release by lysosomal enzymes, which result in remarkable cytotoxicity against cancer cells, are caused by all of the processes that AAC lacks.”
BackgroundJia, J., Ji, W., Xiong, N., Lin, J., & Yang, Q. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.03.011 · Cited by 10
Lengliz, S., Benlabidi, S., Raddaoui, A., Cheriet, S., Chéhida, N. B., Najar, T., & Abbassi, M. S. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13558 · Cited by 10
“In addition, rabbit meat is not prevalent worldwide and even in countries where it is considered as traditional meat species, consumption is presently somewhat regressing (Cullere and Dalle Zotte 2018; Li et al. 2018).”
BackgroundCattle–compost–soil: The transfer of antibiotic resistance in livestock agriculture
Abbas, F., Thomas, P. E. J., Cully‐Duse, B., Andronicos, N. M., & Winter, G. (2023) · MicrobiologyOpen · doi:10.1002/mbo3.1375 · Cited by 10
“MicrobiologyOpen published by John Wiley & Sons Ltd. manufactured antibiotics, respectively, are used for growth promotion in animal production (Lekshmi et al., 2017; Zhang et al., 2015).”
BackgroundChen, Q., Gong, X., Zheng, F., Ji, P., Yuan, Z., Liu, Y., & Wei, Y. (2019) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-19-001 · Cited by 10
Zornu, J., Oyih, M., Binde, M., Viglo, J., Agbekpornu, H., Nkansa, M., Tavornpanich, S., Norheim, K., Brun, E., & Cudjoe, K. S. (2023) · Aquaculture Fish and Fisheries · doi:10.1002/aff2.135 · Cited by 9
Hailu, W., Alemayehu, H., Wolde, D., Hailu, L. T., Medhin, G., Rajashekara, G., Gebreyes, W. A., & Eguale, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-70173-4 · Cited by 9
Exploration of Streptomycetes as Biocontrol Agents Against Plant Pathogens
Jeyaram, M., Jeyaram, Y., Thirumurugan, A., & Gurusamy, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-5803-2_6 · Cited by 10
Assessing the Biological Safety of Dairy Products with Residual Antibiotics
Chaplygina, O., Kozlova, O., Zharko, M., & Petrov, A. (2023) · Food Processing Techniques and Technology · doi:10.21603/2074-9414-2023-1-2427 · Cited by 9
Imai, K., Niwa, R., Fujioka, M., & Ito, K. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad164 · Cited by 9
Khan, Y. M. A., Hernández, J. A., Kariyawasam, S., Butcher, G. D., Czyż, D. M., Pellissery, A. J., & Denagamage, T. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.09.010 · Cited by 12
Metadata
- Authors
- Lekshmi, M., Ammini, P., Kumar, S., & Varela, M. F.
- Affiliations
- Central Institute of Fisheries Education (IN)
- CSIR-National Institute of Oceanography (NIO), Regional Centre, Dr. Salim Ali Road, Kochi 682018, India
- Eastern New Mexico University (US)
- Corresponding author
- Varela, Manuel F.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2017-03-14
- Volume
- 5
- Issue
- 1
- Pages
- 11
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC5374388
- OpenAlex
- W2595170873
- Cited by
- 194
- References
- 122
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 18 · 2023: 37 · 2022: 26 · 2021: 25 · 2020: 30 · 2019: 13 · 2018: 15 · 2017: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Food Safety Authority
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of General Medical Sciences (P20GM103451)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial resistance, food production, zoonotic pathogens, antibiotic growth promoters, foodborne pathogens, Campylobacter, Salmonella, Escherichia coli, Staphylococcus aureus, antibiotic use in livestock, human health risk, critical antimicrobials, trophic transfer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Global antimicrobial use in food animals (a) Major users of antimicrobials in livestock in 2010; (b) Major users of antimicrobials in livestock in 2030 (projected) [65].](https://figures.cochat.ai/paper-figures/0cf0592b99b94604b99caca67c3146f9/the-food-production-environment-and-the-development-of-antimicrobial-resistance-figure-1.jpg)